10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year.
Myos Rens Technology does not have enough data to calculate 10-Year ROIIC %.
Myos Rens Technology 10-Year ROIIC % Historical Data
The historical data trend for Myos Rens Technology's 10-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Myos Rens Technology's 10-Year ROIIC %
For the Drug Manufacturers - Specialty & Generic subindustry, Myos Rens Technology's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Myos Rens Technology's 10-Year ROIIC % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Myos Rens Technology's 10-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Myos Rens Technology's 10-Year ROIIC % falls into.
Myos Rens Technology 10-Year ROIIC % Calculation
Myos Rens Technology's 10-Year ROIIC % for the quarter that ended in Dec. 2019 is calculated as:
10-Year ROIIC %
=
10-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
10-Year Incremental Invested Capital**
=
( -4.218 (Dec. 2019) - -0.039 (Dec. 2009) )
/
( 2.694 (Dec. 2019) - 0 (Dec. 2009) )
=
-4.179
/
=
N/A%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Myos Rens Technology 10-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of Myos Rens Technology's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
Myos Rens Technology (Myos Rens Technology) Business Description
Myos Rens Technology Inc is a US-based bio-nutrition and biotherapeutics company. It focuses on the discovery, development, and commercialization of products that improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases. The company develops nutritional and therapeutic products for maintaining and improving the health and performance of muscle tissue. Its research is focused on developing strategies and therapeutic interventions to address muscle related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases such as Sarcopenia, Cachexia, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MYOS has been successfully added to your 